Camel Milk Modulates the Expression of Aryl Hydrocarbon Receptor-Regulated Genes, Cyp1a1, Nqo1, and Gsta1, in Murine hepatoma Hepa 1c1c7 Cells by Korashy, Hesham M. et al.
Hindawi Publishing Corporation
Journal of Biomedicine and Biotechnology
Volume 2012, Article ID 782642, 10 pages
doi:10.1155/2012/782642
Research Article
Camel MilkModulates the Expression of ArylHydrocarbon
Receptor-Regulated Genes,Cyp1a1,Nqo1,andGsta1, inMurine
hepatomaHepa1c1c7Cells
HeshamM. Korashy,1 Mohamed A. M. El Gendy,2
Abdulqader A. Alhaider,3 andAyman O.El-Kadi2
1Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, 11451 Riyadh, Saudi Arabia
2Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta, Edmonton, AB, Canada T6G 2E1
3Department of Pharmacology, College of Medicine, King Saud University, 11461 Riyadh, Saudi Arabia
Correspondence should be addressed to Ayman O. El-Kadi, aelkadi@pharmacy.ualberta.ca
Received 6 September 2011; Revised 24 October 2011; Accepted 8 November 2011
Academic Editor: Ikhlas A. Khan
Copyright © 2012 Hesham M. Korashy et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
ThereisatraditionalbeliefintheMiddleEastthatcamelmilkmayaidinpreventionandtreatmentofnumerouscasesofcanceryet,
the exact mechanism was not investigated. Therefore, we examined the ability of camel milk to modulate the expression of a well-
known cancer-activating gene, Cytochrome P450 1a1 (Cyp1a1), and cancer-protective genes, NAD(P)H:quinone oxidoreductase
1( Nqo1) and glutathione S-transferase a1 (Gsta1), in murine hepatoma Hepa 1c1c7 cell line. Our results showed that camel milk
signiﬁcantly inhibited the induction of Cyp1a1 gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), the most potent
Cyp1a1 inducer and known carcinogenic chemical, at mRNA, protein, and activity levels in a concentration-dependent manner.
In addition, camel milk signiﬁcantly decreased the xenobiotic responsive element (XRE)-dependent luciferase activity, suggesting
a transcriptional mechanism is involved. Furthermore, this inhibitory eﬀect of camel milk was associated with a proportional
increase in heme oxygenase 1. On the other hand, camel milk signiﬁcantly induced Nqo1 and Gsta1 mRNA expression level in a
concentration-dependent fashion. The RNA synthesis inhibitor, actinomycin D, completely blocked the induction of Nqo1 mRNA
by camel milk suggesting the requirement of de novo RNA synthesis through a transcriptional mechanism. In conclusion, camel
milk modulates the expression of Cyp1a1, Nqo1, and Gsta1 at the transcriptional and posttranscriptional levels.
1.Introduction
The aryl hydrocarbon receptor (AhR), a cytosolic ligand-
activated transcriptional factor, belongs to the basic-helix-
loop-helix (bHLH)/Per-ARNT-Sim (PAS) family of tran-
scription proteins, which are involved in regulation of
cell diﬀerentiation and proliferation [1, 2]. Mechanistically,
AhR is located in the cytoplasm bound with heat shock
protein-90 (HSP90) and AhR interacting protein (AIP)
forming inactive complex. Activation of AhR upon binding
with its ligands, such as 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD), a polycyclic aromatic hydrocarbon (PAH), causes
dissociation of HSP90 and AIP from the activated ligand-
receptor complex, subsequently leading to translocation of
the complex into nucleus. In the nucleus, the ligand-receptor
complex dimerizes with AhR nuclear translocator (ARNT),
which subsequently binds to xenobiotic-responsive element
(XRE) located in the promoter region of so-called AhR-
regulated genes resulting in promoting its transcription and
protein translation processes [3, 4].
The AhR-regulated gene batteries include phase I xeno-
biotic metabolizing enzymes such as the cytochrome P450
1A1 (CYP1A1), CYP1A2, CYP1B1 and phase II enzymes
such as NAD(P)H:quinone oxidoreductase 1 (NQO1), glu-
tathioneS-transferaseA1(GSTA1),uridinediphosphateglu-
curonosyltransferase 1A6, and aldehyde dehydrogenase-3
[3, 4]. Among these genes, CYP1A1 plays a particular role
in bioactivating procarcinogens into carcinogen and toxic2 Journal of Biomedicine and Biotechnology
metabolites and hence is considered as cancer-activating
gene [5], whereas the NQO1 and GSTA1 catalyze reduction
of several environmental contaminants and endogenous
compounds that maintain endogenous antioxidants, such
as ubiquinone and vitamin E, to protect tissues against
mutagens, carcinogens, and oxidative stress damage [6, 7].
Accordingly, one of the strategies for protecting human
cells and tissues from the toxic eﬀects of carcinogenic and
cytotoxic metabolites generally include attenuation of the
carcinogen-activating genes, CYP1A1 signaling pathways,
and/orenhancingtheadaptivemechanismsbyincreasingthe
expression of detoxiﬁcation and antioxidant genes, such as
NQO1 and GSTA1 [8].
Chemoprevention by dietary constituents in the form
of functional food has a well-established beneﬁcial role in
health promotion and emerged as a novel approach to
control cancers [9] .C a m e l ’ sm i l ki sd i ﬀerent from other
ruminantmilk,havinglowcholesterol,lactoferrin,lowsugar,
high minerals (sodium, potassium, iron, copper, zinc and
magnesium), high vitamin C, B2, A, and E, low protein,
and high concentrations of insulin. Recent studies have
reportedthatcamelmilkisthemostactivemilkamongother
species against E. coli, Staphylococcus aureus, Salmonella
typhimurium, and rotavirus [10, 11]. In addition, it has
been demonstrated that milk, in addition to secretory IgA
and IgM, also contains numerous nonantibody compo-
nents that possess antiviral activity, including lactoferrin
[10].
Until recently, it is traditionally claimed that drinking
camel milk may help to ﬁght against serious diseases and
cure numerous cases of cancer; however, this claim has never
been exposed to scientiﬁc scrutiny investigation. Therefore,
the main objective of the current study was to explore the
capacityofcamelmilktomodulatetheexpressionof Cyp1a1,
Nqo1,a n dGsta1 genes as target for cancer prevention in
murine hepatoma Hepa 1c1c7 cells.
2.MaterialsandMethods
2.1. Materials. 7-Ethoxyresoruﬁn (7ER), Dulbecco’s Modi-
ﬁed Eagle’s Medium (DMEM), protease inhibitor cocktail,
sulforaphane (SNF), resveratrol (RES), 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), and
rabbit anti-goat IgG peroxidase secondary antibody were
purchased from Sigma-Aldrich (St. Louis, MO). 2,3,7,8-
Tetrachlorodibenzo-p-dioxin, >99% pure, was purchased
from Cambridge Isotope Laboratories (Woburn, MA).
Resoruﬁn and 100 × vitamin supplements were purchased
from ICN Biomedicals Canada (Montreal, QC). TRIzol
and Lipofectamine 2000 reagents were purchased from
Invitrogen(Carlsbad,CA).TheHigh-CapacitycDNAreverse
transcription kit and SYBR Green PCR Master Mix were
purchased from Applied Biosystems (Foster City, CA).
Actinomycin D (Act-D) was purchased from Calbiochem
(San Diego, CA). Dual-Luciferase Reporter Assay System
was obtained from Promega Corporation (Madison, WI).
Chemiluminescence Western blotting detection reagents
were obtained from GE Healthcare Life Sciences (Piscataway,
NJ). Nitrocellulose membrane was purchased from Bio-
Rad Laboratories (Hercules, CA). Cyp1a1 goat anti-mouse
polyclonal primary antibody, glyceraldehyde-3-phosphate
dehydrogenase (Gapdh) rabbit anti-goat polyclonal anti-
body, and anti-rabbit IgG peroxidase secondary antibodies
were purchased from Santa Cruz Biotechnology (Santa
Cruz, CA). All other chemicals were purchased from Fisher
Scientiﬁc Co. (Toronto, ON).
2.2. Milk Sample Collection and Preparation. Camel milk
was collected aseptically from ﬁve healthy domestic camels
(Camelus dromedaries). The camel milk was collected from
farm and desert living animals. The collection of milk
was usually conducted during the feeding time and was
performed by experienced attendants. Milk was allowed to
ﬂow directly into sterile stainless steel containers and then
transferred to glass vials. Camel samples were transported to
the laboratory as soon as practical (<4h)andwerefrozen
at −80◦C. Aqueous portion (fat-free, skimmed milk) was
removed from the lipids (cream) as described before [12].
Brieﬂy, aliquots of pooled milk samples were centrifuged at
1400×gf o r3 0m i n u t e sa t4 ◦C, thereafter, the creamy layer
consisting largely of fat was removed by ﬁltration through a
glasswoolpluginaPasteurpipette.Camelmilkwascollected
and kept in −80◦C freezer until use.
2.3. Cell Culture and Treatments. Murine hepatoma Hepa
1c1c7 cells (American Type Culture Collection, Manassas,
VA) were maintained in DMEM, without phenol red supple-
mentedwith10%heat-inactivatedfetalbovineserum,20μM
L-glutamine, 100IU/mL penicillin, 10μg/mL streptomycin,
0.1mM nonessential amino acids, and vitamin supplement
solution. Cells were grown in 75cm2 tissue culture ﬂasks at
37◦Cu n d e ra5 %C O 2 humidiﬁed environment.
Hepa 1c1c7 cells were plated onto 96- and six-well cell
culture plates in DMEM culture media for the mRNA,
protein, and catalytic activity assays. In all experiments, the
cells were pretreated for indicated time interval in serum-
free media with various concentrations of camel milk in the
presence or absence of TCDD as indicated. Stock solutions
of TCDD were prepared in dimethyl sulfoxide (DMSO) and
stored at −20◦C, in which the concentration of DMSO did
not exceed 0.05% (v/v).
2.4. Cytotoxicity of Camel Milk. The eﬀects of camel milk
(fat-free) on Hepa 1c1c7 cell viability were determined by
measuringthecapacityofreducingenzymespresentinviable
cells to convert MTT salt to formazan crystals as described
previously [13]. Twenty-four hours after incubating the cells
with the tested milk in the presence and absence of TCDD
in a 96-well cell culture plate at 37◦Cu n d e ra4 %C O 2
humidiﬁed incubator, the media were removed and a 100μL
of serum-free medium containing 1.2mM of MTT dissolved
in phosphate-buﬀered-saline (PBS), pH 7.4, was added to
eachwell.TheplatewasthenincubatedinaCO2 incubatorat
37◦C for 2h. The media were then decanted oﬀ by inverting
the plate, and a 100μL of isopropyl alcohol was added to
each well, with shaking for 1h to dissolve the formazanJournal of Biomedicine and Biotechnology 3
Table 1: Primers sequences used for Real-Time PCR reactions.
Gene Forward primer Reverse primer
Cyp1a1 5 -GGT TAA CCA TGA CCG GGA ACT-3  5 -TGC CCA AAC CAA AGA GAG TGA-3 
Ho-1 5 -GTG ATG GAG CGT CCA CAG C-3  5 -TGG TGG CCT CCT TCA AGG-3 
Nqo1 5 -GGA AGC TGC AGA CCT GGT GA-3  5 -CCT TTC AGA ATG GCT GGC A-3 
Gsta1 5 -CCC CTT TCC CTC TGC TGA AG-3  5 -TGC AGC TTC ACT GAA TCT TGA AAG-3 
β-actin 5 -TAT TGG CAA CGA GCG GTT CC-3  5 -GGC ATA GAG GTC TTT ACG GAT GTC-3 
crystals. The color intensity in each well was measured at
wavelength of 550 using BIO-TEK Instruments EL 312e
microplatereader,Bio-TekInstruments(Winooski,VT).The
percentage of cell viability was calculated relative to control
wells designated as 100% viable cells.
2.5. Determination of Cyp1a1 Enzymatic Activity. Cyp1a1-
dependent 7-ethoxyresoruﬁn (7ER) O-deethylase (EROD)
activity was performed on intact living Hepa 1c1c7 cells
u s i n g7 E Ra sas u b s t r a t e[ 14]. After incubation of the cells
with increasing concentrations of fat-free camel milk for
24h, media were aspirated and the cell monolayers were
rinsed with PBS. Thereafter, 100μLo f2 μM 7ER in assay
buﬀer (0.05M Tris, 0.1M NaCl, pH 7.8) was then added
to each well. Immediately, an initial ﬂuorescence measure-
ment (t = 0) at excitation/emission (545nm/575nm) was
recorded from each well using Baxter 96-well ﬂuorometer
(Deerﬁeld, IL). The plates were then replaced in the incu-
bator, and additional set of ﬂuorescence measurements of
the wells were recorded every 5min for 20min interval. The
amount of resoruﬁn formed in each well was determined by
comparison with a standard curve of known concentrations.
The working solution was then aspirated, the cells were
rinsed twice with PBS, and 50μl of double de-ionized water
was added to lyse the cells. After placing of the cell plates at
−80◦C for 30min, the cell lysates were allowed to thaw, and
protein levels were determined using a modiﬁed ﬂuorescent
assay [15]. The rate of resoruﬁn formation was expressed as
pmol/min/mg protein.
2.6. RNA Extraction and cDNA Synthesis. Total RNA was
isolated using TRIzol reagent (Invitrogen) according to the
manufacturer’s instructions and quantiﬁed by measuring
the absorbance at 260nm. RNA quality was determined by
measuring the 260/280 ratio. Thereafter, ﬁrst strand cDNA
was synthesized using the High-Capacity cDNA reverse
transcription kit (Applied Biosystems) according to the
manufacturer’s instructions. Brieﬂy, 1μgo ft o t a lR N Af r o m
each sample was added to a mix of 2.0μL of 10x reverse
transcriptase buﬀer, 0.8μL of 25x dNTP mix (100mM),
2.0μL of 10x reverse transcriptase random primers, 1.0μLo f
MultiScribe reverse transcriptase, and 3.2μLo fn u c l e a s e - f r e e
water. The ﬁnal reaction mix was kept at 25◦C for 10min,
heated to 37◦C for 120min, heated for 85◦Cf o r5 s ,a n d
ﬁnally cooled to 4◦C[ 16].
2.7. Quantiﬁcation of mRNA Expression by Real-Time Poly-
merase Chain Reaction (RT-PCR). Quantitative analysis of
speciﬁc mRNA expression was performed by RT-PCR by
subjecting the resulting cDNA to PCR ampliﬁcation using
96-well optical reaction plates in the ABI Prism 7500 System
(Applied Biosystems). The 25μL reaction mix contained
0.1μLo f1 0μM forward primer and 0.1μLo f1 0μMr e v e r s e
primer (40nM ﬁnal concentration of each primer), 12.5μL
of SYBR Green Universal Master Mix, 11.15μLo fn u c l e a s e -
free water, and 1.25μLo fc D N As a m p l e .T h ep r i m e r su s e d
in the current study (Table 1)[ 17, 18]w e r ep u r c h a s e df r o m
Integrated DNA Technologies (IDT, Coralville, IA). Assay
controls were incorporated onto the same plate, namely,
no-template controls to test for the contamination of any
assay reagents. The RT-PCR data was analyzed using the
relative gene expression (i.e., ΔΔCT) method, as described
in Applied Biosystems User Bulletin [19]. The data are
presented as the fold change in gene expression normalized
to the endogenous housekeeping gene (β-actin) and was
determinedusingtheequation:foldchange =2−Δ(ΔCt),wher e
ΔCt = Ct(target) − Ct(β-actin) and Δ(ΔCt) = ΔCt(treated) −
ΔCt(untreated).
2.8. Protein Extraction and Western Blot Analysis. Twenty-
four hours after incubating the cells with increasing
concentrations of camel milk (fat-free), the cells were
washed once with cold PBS and collected by scraping
in 100μLo fl y s i sb u ﬀer (50mM HEPES, 0.5M NaCl,
1.5mM MgCl2, 1mM EDTA, 10% (v/v) glycerol, 1%
Triton X-100, and 5μL/mL of protease inhibitor cocktail).
The lysates were incubated on ice for 1h with intermit-
tent vortexing every 10min, followed by centrifugation at
12,000×gf o r1 0 m i na t4 ◦C. The supernatant was then
stored at a −80◦C freezer for later use in the Western blot
analysis.
Western blot analysis was performed as described pre-
viously [20]. For Cyp1a1 immuno-detection, 30μgo fp r o -
teins from each treatment group were diluted with same
amount (1:1) of 2X loading buﬀer (0.1M Tris-HCl, pH
6.8, 4% SDS, 1.5% bromophenol blue, 20% glycerol, 5% β-
mercaptoethanol), boiled and loaded onto a 10% SDS-
polyacrylamide gel. Samples were electrophoresed at 120V
for 2h, and the separated proteins were transferred to
Trans-Blot nitrocellulose membrane (0.45μm) in a buﬀer
containing 25mM Tri-HCl, 192mM glycine, and 20% (v/v)
methanol. Protein blots were blocked overnight at 4◦Ci n
a solution containing 5% skim milk powder, 2% bovine
serum albumin, and 0.5% Tween-20 in TBS solution (0.15M
NaCl, 3mM KCl, 25mM Tris-base). Thereafter, the blocking
solution was removed and the blots were rinsed three times4 Journal of Biomedicine and Biotechnology
in a wash buﬀer (0.1% Tween-20 in TBS). Proteins were
detected by incubation with a primary polyclonal goat anti-
mouse Cyp1a1 antibody for 2h at 4◦C in TBS containing
0.01% sodium azide and 0.05% Tween-20. The primary
antibody solution was removed and blots were rinsed three
times with a wash buﬀer, followed by incubation with
horseradish peroxidase-conjugate rabbit anti-goat secondary
antibody for 1h at room temperature followed by washing
as previously described. Antibody detection was performed
using the enhanced chemiluminescence method. The inten-
sity of Cyp1a1 bands was quantiﬁed, relative to the signals
obtained for Gapdh, using Java-based image-processing
software, ImageJ (W. Rasband (2005) National Institutes of
Health, Bethesda, MD, http://rsb.info.nih.gov/ij/).
2.9. Transient Transfection and Luciferase Assay. Transient
transfection and luciferase assay were carried out as de-
scribed previously [21]. Brieﬂy, Hepa 1c1c7 cells (3 × 104
cells per well) were plated onto 12-well cell culture plates.
Each well was cotransfected with 1.5μg of XRE-driven
luciferase reporter plasmid pGudLuc 1.1 and 0.1μg of the
renilla luciferase pRL-CMV vector, used for normalization.
The pGudLuc 1.1 plasmid was provided as a gift from
Dr. Michael S. Denison (University of California, Davis,
CA), while pRL-CMV vector was obtained from Promega
Corporation(Madison,WI).Transfectionprocedurewascar-
ried out using Lipofectamine 2000 reagent according to the
manufacturer’s instructions (Invitrogen), the luciferase assay
was performed according to the manufacturer’s instructions
(Promega), and luciferase activity was reported as relative
light unit of ﬁreﬂy luciferase to renilla luciferase (Fluc/Rluc).
2.10. Statistical Analysis. All results are presented as mean ±
SEM. The comparative analysis of the results from various
experimental groups with their corresponding controls was
performed using SigmaStat for Windows, Systat Software
Inc., (San Jose, CA). One-way analysis of variance (ANOVA)
followed by Student-Newman-Keul’s test was carried out to
assess the signiﬁcant diﬀerence between diﬀerent groups.
The diﬀerences were considered signiﬁcant when P<0.05.
3. Results
3.1. Eﬀect of Camel Milk on Hepa 1c1c7 Cell Viability. To
determine the cellular toxicity eﬀects of camel milk (fat-
free) in the presence and absence of TCDD on Hepa 1c1c7,
cells were treated for 24h with increasing concentrations
of camel milk (0, 15, 25, 50, 100, and 200μL/mL) in the
presence and absence of TCDD (1nM) and the cell viability
was determined by MTT assay. Figure 1 shows that neither
camel milk alone nor with TCDD were toxic to Hepa 1c1c7
cells at all concentrations of camel milk used, with the
exception of mixture of TCDD plus camel milk (200μL/mL)
that signiﬁcantly decreased cell viability by approximately
25%. Based on these results, concentrations of 0, 25, and
100μL/mL of fat-free camel milk in the presence and
absence of TCDD were chosen to be used in the subsequent
experiments.
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Figure 1: Eﬀect of camel milk on Hepa 1c1c7 cell viability. Hepa
1c1c7 cells were incubated for 24h with various concentrations
of fat-free camel milk (0, 15, 25, 50, 100, and 200μL/mL) in the
presence and absence of TCDD(1nM).Thereafter, cell viability was
assessed using the MTT assay. Values are presented as percentage
of the control (mean ± SEM, n = 8).
∗P < 0.05 compared with
control (concentration = 0μL/mL, nontreated cells).
3.2. Eﬀect of Camel Milk on the TCDD-Mediated Induction
of Cyp1a1 Catalytic Activity in Hepa 1c1c7 Cells. To deter-
mine the capacity of camel milk to alter the induction of
Cyp1a1 catalytic activity by TCDD, Hepa 1c1c7 cells were
preincubated with increasing concentrations of camel milk
(fat-free) (0, 25, and 100μL/mL) or RES (25μM), a positive
control, for 30min before the incubation with 1nM TCDD
for additional 24h. The TCDD 1nM concentration was
selected from our previous concentration-response study
that caused maximum induction of Cyp1a1 gene without
signiﬁcant cell toxicity [22]. Thereafter, Cyp1a1 activity was
determined by EROD assay. Figure 2 shows that TCDD
alone markedly induced Cyp1a1 enzymatic activity level
by 180-fold. Furthermore, camel milk at all concentrations
tested signiﬁcantly inhibited the TCDD-mediated induction
of Cyp1a1 activity by approximately 63% and 80% at the
concentrations of 25 and 100μL/mL, respectively, (Figure 2).
On the other hand, RES, a well-known AhR antagonist,
signiﬁcantly reduced the Cyp1a1 induction by TCDD
(Figure 2). The observed inhibition of Cyp1a1 by camel milk
(fat-free) particularly at the highest concretion is due to a
directeﬀectofcamelmilkandnotbecauseofanycelltoxicity
(Figure 1).
3.3. Eﬀect of Camel Milk on the TCDD-Mediated Induction
of Cyp1a1 mRNA Level in Hepa 1c1c7 Cells. To determine
whether the inhibitory eﬀect of camel milk (fat-free) on the
TCDD-mediated induction of Cyp1a1 activity (Figure 2)i s
attributed to a transcriptional mechanism, Cyp1a1 mRNA
levels were determined in Hepa 1c1c7 cells treated for 6h
with TCDD (1nM) in the presence and absence of diﬀerent
concentrations of camel milk (0, 25, and 100μL/mL) or
RES (25μM) as positive control. Our results showed thatJournal of Biomedicine and Biotechnology 5
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Figure 2: Eﬀect of camel milk on the TCDD-mediated induction
of Cyp1a1 activity. Hepa 1c1c7 cells were treated for 24 with
TCDD (1nM) in the presence and absence of camel milk (0, 25,
and 100μL/mL) or the positive control, resveratrol (Res, 25μM).
Cyp1a1 activity was measured in intact living cells using EROD
assay. Values are presented as mean ± SEM (n = 8). +P < 0.05
compared with control (sterile water-treated cells),
∗P < 0.05
compared with TCDD-treated cells.
TCDD signiﬁcantly induced Cyp1a1 mRNA level by approx-
imately 15-fold (Figure 3). Importantly, incubation of Hepa
1c1c7 cells with camel milk (fat-free) signiﬁcantly decreased
the TCDD-mediated induction of Cyp1a1 mRNA in a
concentration-dependentmanner (Figure 3).Themaximum
inhibition (90%) was observed at the highest concentration
tested (100μL/mL) (Figure 3) .S i m i l a rt oC y p 1 a 1a c t i v i t y ,
the positive control RES signiﬁcantly decreased the TCDD-
mediated induction of Cyp1a1 mRNA (Figure 3).
3.4. Eﬀect of Camel Milk on the TCDD-Mediated Induction
of Cyp1a1 Protein in Hepa 1c1c7 Cells. To further investi-
gate whether the obtained inhibition on TCDD-mediated
inductionofCyp1a1mRNAlevelsbycamelmilkistranslated
into a functional Cyp1a1 protein, Western blot analysis was
carried out. Total protein was isolated from Hepa 1c1c7 cells
treated for 24h with TCDD (1nM) in the presence and
absence of diﬀerent concentrations of camel milk (fat-free)
(0, 25, and 100μL/mL). Figure 4 shows that the induction of
Cyp1a1proteinbyTCDD(72-fold)wassigniﬁcantlyreduced
by camel milk (fat-free) by approximately 30% and 65%
at concentrations of 25 and 100μL/mL, respectively. This
pattern of inhibition is similar to what was observed at the
activity and mRNA level (Figures 2 and 3).
Taken together, these results showed that camel milk
stands prominently in its inhibition of the induction of
Cyp1a1 gene expression at the activity, mRNA, and protein
levels.
3.5. Eﬀect of Camel Milk on XRE-Dependent Luciferase Activ-
ity. To explore the ability of fat-free camel milk to inhibit
the AhR-dependent reporter gene expression, Hepa 1c1c7
3
6
9
12
15
18
(
f
o
l
d
 
o
f
 
I
n
d
u
c
t
i
o
n
)
 
C
y
p
1
a
1
 
m
R
N
A
 
l
e
v
e
l
Camel milk (µL/mL)
TCDD (1 nM)
RES (25 µM)
−
−
−−−−
−
++++
+
0 25 100
∗
∗
∗
+
Figure 3: Eﬀect of camel milk on the TCDD-mediated induction
of Cyp1a1 mRNA. Hepa 1c1c7 cells were treated for 6h with TCDD
(1nM) in the presence and absence of camel milk (fat-free) (0, 25,
and 100μL/mL) or the positive control, resveratrol (Res, 25μM).
The amount of Cyp1a1 mRNA was quantiﬁed using real-time PCR
and normalized to β-actin housekeeping gene. Duplicate reactions
wereperformedforeachexperiment,andthevaluesrepresentmean
of fold change ± SEM. (n = 4). +P < 0.05 compared with control
(sterile water-treated cells),
∗P < 0.05 compared with TCDD-
treated cells.
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Figure 4: Eﬀect of camel milk on the TCDD-mediated induction
of Cyp1a1 protein. Hepa 1c1c7 cells were treated for 24 with TCDD
(1nM) in the presence and absence of camel milk (fat-free) (0, 25,
and 100μL/mL); thereafter, Cyp1a1 protein level was determined
by Western blot analysis and was detected using the enhanced
chemiluminescence method. The intensity of Cyp1a1 protein bands
was quantiﬁed relative to the signals obtained for Gapdh protein,
using ImageJ. One of the three representative experiments is shown
and values represent mean of fold change ± SEM. (n = 3). +P <
0.05 compared with control (sterile water-treated cells),
∗P < 0.05
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Figure 5: Eﬀect of camel milk on XRE-dependent luciferase
activity. Hepa 1c1c7 cells were transiently cotransfected with
XRE-driven luciferase reporter plasmid pGudLuc 1.1. and renilla
luciferase control plasmid pRL-CMV. Cells were treated with sterile
water or camel milk (fat free, 100μL/mL) 30 min before the
addition of TCDD (1nM) for an additional 24h. Cells were lysed
and luciferase activity was reported as relative light unit (RLU) of
ﬁreﬂy luciferase to renilla luciferase (Fluc/Rluc) (mean ± S.E.M.,
n = 4). +P < 0.05 compared control (sterile water-treated cells),
∗P < 0.05 compared with TCDD-treated cells.
cells were transiently cotransfected with the XRE-dependent
luciferase reporter gene and renilla luciferase vector, which
was used for normalization of transfection eﬃciency. Cells
were then incubated for 24h with TCDD (InM) in the
presenceandabsenceofcamelmilk(100μL/mL).Ourresults
showed that TCDD signiﬁcantly induced XRE-dependent
luciferase activity by approximately 7-fold (Figure 5).
Importantly, camel milk (fat-free, 100μL/mL) completely
blocked the induction of XRE-dependent luciferase activity
by TCDD to its control level (Figure 5).
3.6. Eﬀect of Camel Milk on Ho-1 mRNA in Hepa 1c1c7
Cells. The capacity of camel milk to inhibit TCDD-mediated
induction of Cyp1a1 at the activity level more than at the
protein levels prompted us to investigate the possible role
of Ho-1, a rate-limiting enzyme of heme degradation, in
this inhibitory eﬀect. For this purpose, Ho-1 mRNA level
was determined in Hepa 1c1c7 cells treated with increasing
concentrations of camel milk (0, 25, and 100μL/mL) or
SFN (5μM), as a positive control, for 6h. Our results show
that camel milk (fat-free) signiﬁcantly increased the Ho-1
mRNA expression level by the highest concentration tested
(100μL/mL) by approximately 3-fold (Figure 6). Similarly,
SFN caused a 9-fold induction in Ho-1 mRNA level. These
data may suggest a role for Ho-1 in camel milk-mediated
eﬀects.
3.7. Eﬀect of Camel Milk on Nqo1 and Gsta1 mRNA Levels in
Hepa 1c1c7 Cells. To further investigate whether camel milk
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Figure 6: Eﬀect of camel milk on Ho-1 mRNA expression level.
Hepa 1c1c7 cells were treated for 6h with increasing concentrations
of fat-free camel milk (0, 25, and 100μL / m L )o rS F N( 5μM), as
a positive control. The amount of Ho-1 mRNA was quantiﬁed
using real-time PCR and normalized to β-actin housekeeping gene.
Duplicate reactions were performed for each experiment, and the
values represent mean of fold change ± SEM. (n = 4). +P < 0.05
compared with control (sterile water-treated cells).
(fat-free) is able to increase the expression of chemoprotec-
tive genes, Nqo1 and Gsta1 mRNA levels were measured in
Hepa 1c1c7 cells treated for 6 h with camel milk (0, 25, and
100μL/mL) or SFN (5μM), as a positive control. Figure 7
shows that camel milk (fat-free) signiﬁcantly induced Nqo1
and Gsta1 mRNA levels by approximately 2.5- and 8-fold,
respectively,atthehighestconcentrationtested(100μL/mL).
A similar induction was observed with SFN, strong inducer
of Nqo1 and Gsta1 (Figure 7).
3.8. Eﬀect of Transcription Inhibitor, Act-D, on Camel-Milk-
Induced Nqo1 mRNA Levels. To further investigate whether
camel milk (fat-free) is able to increase the de novo Nqo1
RNA synthesis, Hepa 1c1c7 cells were treated with Act-D
(5μg/mL, RNA synthesis inhibitor) immediately before the
addition of camel milk (fat-free, 100μL/mL) for additional
6h. Thereafter, Nqo1 mRNA was quantiﬁed by real-time
PCR. If camel milk increases the amount of Nqo1 mRNA
throughatranscriptionalmechanism,adecreaseintheNqo1
mRNA level would be expected. Figure 8 shows that Act-D
slightly but signiﬁcantly inhibited the constitutive expression
of Nqo1 mRNA, whereas markedly blocked the camel milk-
induced Nqo1 mRNA by approximately 70% (Figure 8).
4. Discussion
The current study provides the ﬁrst mechanistic evidence of
theability ofcamelmilk tosigniﬁcantlyinhibit the induction
of Cyp1a1, a cancer-activating gene, and to induce Nqo1 and
Gsta1, cancer protecting genes in Hepa 1c1c7 cells at the
transcriptional and posttranscriptional levels.
One of the strategies for protecting human cells and
tissues from the toxic eﬀects of carcinogenic and cytotoxic
metabolites include attenuation of the carcinogen-activatingJournal of Biomedicine and Biotechnology 7
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Figure 7: Eﬀect of camel milk on Nqo1 (a) and Gsta1 (b) mRNA expression levels. Hepa 1c1c7 cells were treated for 6 h with fat-free camel
milk (0, 25, and 100μL/mL) or SFN (5μM), as a positive control. The amount of Nqo1 and Gsta1 mRNA levels was quantiﬁed using real-
time PCR and normalized to β-actin housekeeping gene. Duplicate reactions were performed for each experiment and the values represent
mean of fold change ± SEM. (n = 4). +P < 0.05 compared with control (sterile water-treated cells).
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Figure 8: Eﬀect of transcription inhibitor, Act-D, on the induction
of Nqo1 mRNA by camel milk. Hepa 1c1c7 cells were incubated
with the transcription inhibitor, Act-D (5μg/mL), immediately
before the addition of fat-free camel milk (100μL/mL) for 6h. The
amount of Nqo1 mRNA was quantiﬁed using real-time PCR and
normalized to β-actin housekeeping gene. Duplicate reactions were
performed for each experiment, and the values represent mean
of fold change ± SEM. (n = 4). +P < 0.05 compared with
control (sterile water-treated cells),
∗P < 0.05 compared with
corresponding treatment in the absence of Act-D.
genes signaling pathways and/or enhancing the adaptive
mechanisms by increasing the expression of detoxiﬁcation
and antioxidant genes. Accordingly, we hypothesize that
camel milk exhibits anticancer eﬀects by inhibiting the
expressionof Cyp1a1 and/orinducingNqo1andGsta1genes.
Therefore, to test our hypothesis we examined the capacity
of camel milk to (a) inhibit the induction of Cyp1a1 at the
mRNA, protein, and activity levels, (b) induce the expression
of Nqo1, and Gsta1 mRNA levels in Hepa 1c1c7 cells, and (c)
explore the underlying molecular mechanism.
Several lines of evidence showed that induction of
CYP1A1 is strongly correlated with increased incidence of
several human colon, rectal, and lung cancers [23, 24]. In
addition, studies on the carcinogenicity and mutagenicity
of PAHs have demonstrated a signiﬁcant role for the
induction of CYP1A1 in bioactivating these environmental
toxicants into their ultimate carcinogenic forms [25]. Thus
Cyp1a1 induction is considered a useful biomarker of
exposure to carcinogenic substances [26]. Accordingly, we
have ﬁrst examined the potential eﬀect of camel milk on
the expression of Cyp1a1 gene after induction by TCDD
using EROD as a probe for Cyp1a1 activity [27]. Our
resultsshowedthatcamelmilk(fat-free)atallconcentrations
tested reduced Cyp1a1 EROD activity in a concentration-
dependent manner (Figure 2). Importantly, the modulation
ofCyp1a1activitybycamelmilkisattributedtoadecreasein
transcriptional and translational regulation of Cyp1a1 gene.
This was evidenced by the ability of camel milk to alter
the expression of Cyp1a1 at the mRNA and protein levels
(Figures 3 and 4).
The transcriptional regulation of Cyp1a1 and Nqo1 genes
by camel milk (fat-free) was demonstrated by several lines of
evidence. First, the inhibition of XRE-dependent luciferase
assay that occurs only through the AhR activation sug-
gests an AhR-dependent transcriptional control (Figure 5).
Second, the ability of the transcription inhibitor, Act-D,
to signiﬁcantly block the newly synthesized Nqo1 mRNA
(Figure 7) suggests a requirement of de novo RNA synthesis
for the induction of Nqo1 mRNA by camel milk. Taken
together, these results strongly suggest that the inhibition
of Cyp1a1 and induction of Nqo1 genes by camel milk is
mediated, at least in part, at the transcriptional level.
Interestingly, the observation that camel milk-mediated
inhibition of Cyp1a1 induction by TCDD at the activity8 Journal of Biomedicine and Biotechnology
levels is higher than those observed at the protein levels
(Figure 2), suggest that a possible involvement of a post-
translational mechanism, such as phosphorylation, protea-
somal degradations, modulation of HO-1 gene expression,
could be involved [22, 28]. Among these mechanisms,
HO-1 gene expression, a rate-limiting enzyme in heme
catabolism, has been shown to alter cellular heme, the
prosthetic group of CYP450, content and hence the enzyme
activity [29]. To test this hypothesis, we have examined the
eﬀect of camel milk (fat-free) on the expression of Ho-
1 mRNA level. Our results showed that the camel milk
increases the level of Ho-1 mRNA levels (Figure 6). Taken
together, we postulated here that the capacity of camel
milk to induce the expression of Ho-1 mRNA resulted in
a decrease in Cyp1a1 activity levels through degrading its
heme content. This postulation is supported by our previ-
ous observations that in mesoporphyrin, competitive Ho-1
inhibitor or knockdown of Ho-1 using siRNA signiﬁcantly
restored the inhibition of Cyp1a1 activity by heavy metals
[30, 31].
The chemo protective eﬀect of camel milk was further
supported, in addition to inhibition of Cyp1a1, by the ability
to upregulate antioxidant genes, particularly Nqo1 and
Gsta1 mRNA levels in a concentration-dependent manner
(Figure 7). Our results are in agreement with previous stud-
ies that reported the ability of camel milk to induce GST
levels in healthy and schistosoma-infected mice [32]. Thus
increased expression of Nqo1 and Gsta1 by camel milk
will increase the levels of several antioxidant enzymes which
prevent the formation of highly reactive oxygen radicals and
hence reduce DNA adduct and cell damage [33]. In addition,
overexpression of NQO1 in several human solid tumors
and cancer cells has been shown to activate bioreductive
chemotherapeutic agents in tumor cells that allow tumor
cytotoxicity without corresponding toxicity to normal cells
[34].
Although the potential mediators in camel milk involved
in the downregulation of Cyp1a1 and induction of Nqo1
and Gsta1 were not examined in this study, several previous
studies have reported that camel milk contains considerably
higher amounts of antioxidant vitamins, such as E and C,
in comparison to cow milk [35], lysosomes [11], lactoferrins
[11, 36], and immunoglobulines [36]. In addition, ongoing
research in our laboratory has shown the presence of several
compounds in camel milk that could be involved in milk-
mediated eﬀect (unpublished data). Among these mediators,
lactoferrin, an iron-binding glycoprotein, is known to exert
in vitro and in vivo antitumor activity [37]. In this context,
it has been recently reported that lactoferrin inhibits the
development of cancer through inhibiting CYP1A1 activa-
tion in 7,12-dimethylbenz[a]anthracene- (DMBA-) induced
hamster buccal pouch carcinoma model. Taken together
the results obtained from our laboratory and previously
published reports, we speculate that lactoferrin could be
responsible for camel-milk-mediated eﬀect. In addition, the
main components of the camel milk have been already
determined [38]. Ongoing research in our laboratory focuses
on identifying and characterizing the most eﬀective com-
ponent of camel milk using liquid chromatography-tandem
mass spectrometry (LC-MS/MS) and one-dimensional gel
electrophoresis, where several proteins were found to be
relatively abundant in camel milk (data not shown).
In conclusion, the results of current study suggest that
camel milk could protect against or decrease the del-
eterious eﬀects of many environmental toxicants and car-
cinogens such as PAHs, probably through modulation of
AhR-regulated genes of Cyp1a1, Nqo1,a n dGsta1 at the
transcriptional and posttranscriptional mechanisms. These
results are of potential clinical signiﬁcance to humans in that
it uncovers the molecular mechanism involved and could
explaintheanecdotalevidenceforthesuccessfuluseofcamel
milk in the treatment and/or prevention of various medical
conditions.
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